96P: Enhanced anti-tumor activity of zelenectide pevedotin in patients (pts) with non-small cell lung cancer (NSCLC) with NECTIN4 gene amplification (amp)

  • L. Verlingue
  • , N. Klümper
  • , M. Eckstein
  • , J. Braegelmann
  • , M. McKean
  • , A. Italiano
  • , L. Carter
  • , G.S. Falchook
  • , V. Boni
  • , A. Dowlati
  • , B. Doger De Spéville
  • , E. Fontana
  • , J. Rodon
  • , L. Demars
  • , G. Brown
  • , C. Xu
  • , C. Campbell
  • , T. Gelb
  • , S. Santos
  • , C. Baldini

Research output: Contribution to conference › Abstract › peer-review

Fingerprint

Dive into the research topics of '96P: Enhanced anti-tumor activity of zelenectide pevedotin in patients (pts) with non-small cell lung cancer (NSCLC) with NECTIN4 gene amplification (amp)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science